You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
佐力藥業(300181.SZ):華東地區包含了中藥飲片和配方顆粒的銷售收入
格隆匯 06-15 08:01

格隆匯6月15日丨佐力藥業(300181.SZ)召開線上會議,就“公司華東地區銷售佔比較高的原因是什麼?對於其他地區的放量空間怎麼看?”

公司回覆稱,1、華東地區包含了中藥飲片和配方顆粒的銷售收入,而中藥飲片和配方顆粒的銷售基本都在浙江省內,所以整體銷售佔比較高。2、公司本身位於浙江省,本身業務在華東地區首先開展,且華東地區的經濟發達也有優勢利於公司產品的銷售。對於關注未來放量空間:一是本身銷量較好的華東地區本身還有放量空間;二是公司在廣東聯盟和北京市等集采地區,都在慢慢實現放量,包括近幾年河南等省市銷售增量也相對比較明顯;三是未來公司的中藥配方顆粒完成較多的國標備案後將會在全國範圍內逐步進行銷售,這也是一塊銷售增量。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account